Emglif-L 10/5Mg Tab 28S

Emglif-L 10/5mg contains Empagliflozin 10mg + Linagliptin 5mg, a combination oral antidiabetic medicine used to improve blood glucose control in adults with Type 2 diabetes. It is manufactured by Genix Pharma.

• Helps lower and control blood sugar levels alongside diet and exercise.
• Empagliflozin helps the kidneys remove excess glucose through urine.
• Linagliptin helps increase insulin release and reduce glucagon when blood glucose is elevated.
• The combination provides complementary mechanisms for improved glycemic control.
• May cause increased urination, dehydration, urinary/genital infections, or gastrointestinal discomfort.
• Take only as prescribed by a healthcare professional and maintain adequate hydration.